BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 15093563)

  • 1. Differential regulation of lymphoproliferative responses to Trypanosoma cruzi antigen in patients with the cardiac or indeterminate form of Chagas disease.
    de Barros-Mazon S; Guariento ME; da Silva CA; Coffman RL; Abrahamsohn IA
    Clin Immunol; 2004 Apr; 111(1):137-45. PubMed ID: 15093563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the cellular immune response in patients with the digestive and indeterminate forms of Chagas' disease.
    Ribeiro BM; Crema E; Rodrigues V
    Hum Immunol; 2008 Aug; 69(8):484-9. PubMed ID: 18582517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon- or interleukin-10 production is induced by related Trypanosoma cruzi antigens.
    Cuna WR; Encina JL; Cuna CR
    J Parasitol; 2000 Apr; 86(2):295-9. PubMed ID: 10780548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-10 and IFN-γ gene expression in chronic Chagas disease patients after in vitro stimulation with recombinant antigens of Trypanosoma cruzi.
    de Melo AS; de Lorena VM; de Moura Braz SC; Docena C; de Miranda Gomes Y
    Cytokine; 2012 May; 58(2):207-12. PubMed ID: 22325340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammatory mediators from monocytes down-regulate cellular proliferation and enhance cytokines production in patients with polar clinical forms of Chagas disease.
    Gomes JA; Molica AM; Keesen TS; Morato MJ; de Araujo FF; Fares RC; Fiuza JA; Chaves AT; Pinheiro V; Nunes Mdo C; Correa-Oliveira R; da Costa Rocha MO
    Hum Immunol; 2014 Jan; 75(1):20-8. PubMed ID: 24071371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strategy to assess the overall cytokine profile of circulating leukocytes and its association with distinct clinical forms of human Chagas disease.
    Vitelli-Avelar DM; Sathler-Avelar R; Teixeira-Carvalho A; Pinto Dias JC; Gontijo ED; Faria AM; Elói-Santos SM; Martins-Filho OA
    Scand J Immunol; 2008 Nov; 68(5):516-25. PubMed ID: 18803607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-12 enhances proliferation of peripheral blood mononuclear cells from Chagas' disease patients to Trypanosoma cruzi antigen.
    de Barros-Mazon S; Guariento ME; Abrahamsohn IA
    Immunol Lett; 1997 Jun; 57(1-3):39-45. PubMed ID: 9232423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trypanosoma cruzi infection induces differential modulation of costimulatory molecules and cytokines by monocytes and T cells from patients with indeterminate and cardiac Chagas' disease.
    Souza PE; Rocha MO; Menezes CA; Coelho JS; Chaves AC; Gollob KJ; Dutra WO
    Infect Immun; 2007 Apr; 75(4):1886-94. PubMed ID: 17283096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proliferation and bystander suppression induced by membrane and flagellar antigens of Trypanosoma cruzi.
    Mosca W; Briceño L
    Invest Clin; 2009 Mar; 50(1):77-87. PubMed ID: 19418729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of proinflammatory cytokines on Actinobacillus actinomycetemcomitans specific IgG responses.
    Tanaka S; Fakher M; Barbour SE; Schenkein HA; Tew JG
    J Periodontal Res; 2006 Feb; 41(1):1-9. PubMed ID: 16409249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokine levels in serious cardiopathy of Chagas disease after in vitro stimulation with recombinant antigens from Trypanosoma cruzi.
    Lorena VM; Lorena IM; Braz SC; Melo AS; Melo MF; Melo MG; Silva ED; Ferreira AG; Morais CN; Costa VM; Correa-Oliveira R; Gomes YM
    Scand J Immunol; 2010 Dec; 72(6):529-39. PubMed ID: 21044127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-12 stimulation of lymphoproliferative responses in Trypanosoma cruzi infection.
    Galvão da Silva AP; de Almeida Abrahamsohn I
    Immunology; 2001 Nov; 104(3):349-54. PubMed ID: 11722650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Humoral and cellular immune response of adults from northeastern Brazil with chronic Trypanosoma cruzi infection: depressed cellular immune response to T. cruzi antigen among Chagas' disease patients with symptomatic versus indeterminate infection.
    Cetron MS; Basilio FP; Moraes AP; Sousa AQ; Paes JN; Kahn SJ; Wener MH; Van Voorhis WC
    Am J Trop Med Hyg; 1993 Sep; 49(3):370-82. PubMed ID: 8372959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benznidazole treatment during early-indeterminate Chagas' disease shifted the cytokine expression by innate and adaptive immunity cells toward a type 1-modulated immune profile.
    Sathler-Avelar R; Vitelli-Avelar DM; Massara RL; Borges JD; Lana M; Teixeira-Carvalho A; Dias JC; Elói-Santos SM; Martins-Filho OA
    Scand J Immunol; 2006 Nov; 64(5):554-63. PubMed ID: 17032249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trypanosomal immunosuppressive factor: a secretion product(s) of Trypanosoma cruzi that inhibits proliferation and IL-2 receptor expression by activated human peripheral blood mononuclear cells.
    Kierszenbaum F; Cuna WR; Beltz LA; Sztein MB
    J Immunol; 1990 May; 144(10):4000-4. PubMed ID: 2185317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Chagas disease. Serologic response to crude and semipurified T. cruzi antigens in different clinical groups of patients].
    Cervetta L; Basso B; Castro I; Santamarina N; Moretti E
    Medicina (B Aires); 1997; 57(2):161-8. PubMed ID: 9532826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired phagocytic capacity driven by downregulation of major phagocytosis-related cell surface molecules elicits an overall modulatory cytokine profile in neutrophils and monocytes from the indeterminate clinical form of Chagas disease.
    Gomes JA; Campi-Azevedo AC; Teixeira-Carvalho A; Silveira-Lemos D; Vitelli-Avelar D; Sathler-Avelar R; Peruhype-Magalhães V; Silvestre KF; Batista MA; Schachnik NC; Correa-Oliveira R; Eloi-Santos S; Martins-Filho OA
    Immunobiology; 2012 Oct; 217(10):1005-16. PubMed ID: 22387073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of anti-Trypanosoma cruzi antibody isotype specificities by western blot in sera from patients with different forms of Chagas' disease.
    Morgan J; Colley DG; Pinto Dias JC; Gontijo ED; Bahia-Oliveira L; Correa-Oliveira R; Powell MR
    J Parasitol; 1998 Jun; 84(3):641-3. PubMed ID: 9645878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune response to Leishmania antigen in anthroponotic cutaneous leishmaniasis.
    Ajdary S; Riazi-Rad F; Alimohammadian MH; Pakzad SR
    J Infect; 2009 Aug; 59(2):139-43. PubMed ID: 19560211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of LACK and KMP11 on IFN-gamma production by peripheral blood mononuclear cells from cutaneous and mucosal leishmaniasis patients.
    Carvalho LP; Passos S; Dutra WO; Soto M; Alonso C; Gollob KJ; Carvalho EM; Ribeiro de Jesus A
    Scand J Immunol; 2005 Apr; 61(4):337-42. PubMed ID: 15853916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.